APA

Abdolahpour S., Toliyat T., Omidfar K., Modjtahedi H., Wong A. J., Rasaee M. J., Kashanian S. & Paknejad M. (20180801). Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody. : Artificial cells, nanomedicine, and biotechnology.

Chicago

Abdolahpour Saeideh, Toliyat Tayebeh, Omidfar Kobra, Modjtahedi Helmout, Wong Albert J, Rasaee Mohammad Javad, Kashanian Susan and Paknejad Maliheh. 20180801. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody. : Artificial cells, nanomedicine, and biotechnology.

Harvard

Abdolahpour S., Toliyat T., Omidfar K., Modjtahedi H., Wong A. J., Rasaee M. J., Kashanian S. and Paknejad M. (20180801). Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody. : Artificial cells, nanomedicine, and biotechnology.

MLA

Abdolahpour Saeideh, Toliyat Tayebeh, Omidfar Kobra, Modjtahedi Helmout, Wong Albert J, Rasaee Mohammad Javad, Kashanian Susan and Paknejad Maliheh. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody. : Artificial cells, nanomedicine, and biotechnology. 20180801.